Biogen Stock Options Expiring on 17th of January 2025

BIIB Stock  USD 230.63  0.59  0.26%   
Biogen's latest option contracts expiring on 2025-01-17 are carrying combined implied volatility of 30.25 with a put-to-call open interest ratio of 1.21 over 136 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on 2025-01-17. The current put volume is at 1, with calls trading at the volume of 103. This yields a 0.01 put-to-call volume ratio. The Biogen option chain provides detailed quote and price information for the current Biogen Inc option contracts. It shows all of Biogen's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2025-01-17 Option Contracts

Biogen option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Biogen's lending market. For example, when Biogen's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Biogen, he or she must hedge the risk by shorting Biogen stock over its option's life.
The chart above shows Biogen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biogen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biogen's option, there is no secondary market available for investors to trade.

Biogen Maximum Pain Price across 2025-01-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Biogen close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Biogen's stock options are financial instruments that give investors the right to buy or sell shares of Biogen Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biogen stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biogen's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Please note that buying 'in-the-money' options on Biogen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Biogen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Biogen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Biogen Stock moves the wrong way.
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B).

Biogen Inc In The Money Call Balance

When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying Biogen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Biogen Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Biogen Current Options Market Mood

Biogen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biogen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Biogen's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Biogen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Biogen's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Biogen contract

Base on the Rule 16, the options market is currently suggesting that Biogen Inc will have an average daily up or down price movement of about 1.89% per day over the life of the 2025-01-17 option contract. With Biogen trading at USD 230.63, that is roughly USD 4.36. If you think that the market is fully incorporating Biogen's daily price movement you should consider buying Biogen Inc options at the current volatility level of 30.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Biogen Option Chain

When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biogen's option chain is a display of a range of information that helps investors for ways to trade options on Biogen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biogen. It also shows strike prices and maturity days for a Biogen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2025-01-17 CALL at $100.00.97455.0E-422025-01-17131.0 - 139.0143.25In
Call
2025-01-17 CALL at $105.00.96926.0E-4102025-01-17126.0 - 135.00.0In
Call
2025-01-17 CALL at $110.00.96976.0E-482025-01-17121.0 - 130.00.0In
Call
2025-01-17 CALL at $115.00.96397.0E-482025-01-17117.0 - 125.00.0In
Call
2025-01-17 CALL at $120.00.96438.0E-472025-01-17112.0 - 120.0187.9In
Call
2025-01-17 CALL at $125.00.9589.0E-402025-01-17107.0 - 116.00.0In
Call
2025-01-17 CALL at $130.00.96129.0E-402025-01-17102.0 - 110.60.0In
Call
2025-01-17 CALL at $135.00.95870.00102025-01-1797.0 - 106.00.0In
Call
2025-01-17 CALL at $140.00.94390.001302025-01-1793.0 - 102.00.0In
Call
2025-01-17 CALL at $145.00.94340.001412025-01-1788.0 - 97.069.3In
Call
2025-01-17 CALL at $150.00.9430.001572025-01-1783.0 - 92.087.3In
Call
2025-01-17 CALL at $155.00.93510.001702025-01-1779.0 - 86.90.0In
Call
2025-01-17 CALL at $160.00.92130.00212025-01-1775.0 - 82.564.0In
Call
2025-01-17 CALL at $165.00.91240.0023112025-01-1770.2 - 78.2130.3In
Call
2025-01-17 CALL at $170.00.89640.002622025-01-1766.1 - 74.154.9In
Call
2025-01-17 CALL at $175.00.88480.002932025-01-1761.0 - 70.399.95In
Call
2025-01-17 CALL at $180.00.86310.003222025-01-1758.2 - 65.753.5In
Call
2025-01-17 CALL at $185.00.83480.00351282025-01-1756.1 - 61.850.96In
Call
2025-01-17 CALL at $190.00.83250.00442025-01-1750.1 - 56.543.6In
Call
2025-01-17 CALL at $195.00.8040.004322025-01-1747.0 - 53.346.0In
Call
2025-01-17 CALL at $200.00.77550.0045362025-01-1744.8 - 49.549.0In
Call
2025-01-17 CALL at $205.00.75890.0051102025-01-1738.5 - 46.321.15In
Call
2025-01-17 CALL at $210.00.72580.00521892025-01-1735.5 - 43.740.0In
Call
2025-01-17 CALL at $215.00.69510.0054142025-01-1734.7 - 40.339.9In
Call
2025-01-17 CALL at $220.00.66710.0057422025-01-1731.8 - 36.731.0In
Call
2025-01-17 CALL at $225.00.63750.006212025-01-1728.2 - 34.134.45In
Call
2025-01-17 CALL at $230.00.60670.00611252025-01-1726.2 - 31.419.52In
Call
2025-01-17 CALL at $235.00.57450.0066102025-01-1723.3 - 27.125.32Out
Call
2025-01-17 CALL at $240.00.54190.0067362025-01-1721.1 - 26.822.9Out
Call
2025-01-17 CALL at $245.00.51170.0066212025-01-1719.2 - 23.419.4Out
Call
2025-01-17 CALL at $250.00.47560.00691742025-01-1717.1 - 19.918.4Out
Call
2025-01-17 CALL at $255.00.43940.0071912025-01-1712.0 - 19.918.0Out
Call
2025-01-17 CALL at $260.00.40510.0071982025-01-1710.0 - 18.014.6Out
Call
2025-01-17 CALL at $265.00.37560.00691982025-01-178.7 - 16.610.0Out
Call
2025-01-17 CALL at $270.00.34280.00682612025-01-178.2 - 12.911.0Out
Call
2025-01-17 CALL at $275.00.32360.0064672025-01-179.1 - 11.910.5Out
Call
2025-01-17 CALL at $280.00.30520.0061802025-01-177.5 - 12.410.5Out
Call
2025-01-17 CALL at $285.00.26080.0062452025-01-173.9 - 11.37.76Out
Call
2025-01-17 CALL at $290.00.24120.0057562025-01-173.7 - 10.27.95Out
Call
2025-01-17 CALL at $295.00.2220.0054602025-01-173.1 - 9.54.8Out
Call
2025-01-17 CALL at $300.00.21330.00513782025-01-174.1 - 8.36.26Out
Call
2025-01-17 CALL at $305.00.17570.0048632025-01-173.2 - 6.03.0Out
Call
2025-01-17 CALL at $310.00.17010.0045682025-01-171.45 - 7.75.2Out
Call
2025-01-17 CALL at $375.00.02450.0011312025-01-170.0 - 5.00.43Out
Call
2025-01-17 CALL at $450.00.05110.0013672025-01-170.05 - 3.00.45Out
 Put
2025-01-17 PUT at $105.0-0.01384.0E-4402025-01-170.05 - 1.00.6Out
 Put
2025-01-17 PUT at $140.0-0.05840.0013182025-01-170.05 - 5.11.75Out
 Put
2025-01-17 PUT at $175.0-0.10380.0029572025-01-171.4 - 5.54.67Out
 Put
2025-01-17 PUT at $180.0-0.12430.00334372025-01-173.4 - 7.34.3Out
 Put
2025-01-17 PUT at $185.0-0.15370.00371032025-01-172.65 - 9.16.0Out
 Put
2025-01-17 PUT at $190.0-0.1790.0043292025-01-174.1 - 10.35.88Out
 Put
2025-01-17 PUT at $195.0-0.2010.00453272025-01-175.4 - 10.98.5Out
 Put
2025-01-17 PUT at $200.0-0.21010.00684292025-01-175.0 - 10.07.8Out
 Put
2025-01-17 PUT at $205.0-0.24820.00541752025-01-176.1 - 13.79.1Out
 Put
2025-01-17 PUT at $210.0-0.27680.0059942025-01-177.7 - 14.510.4Out
 Put
2025-01-17 PUT at $215.0-0.31690.0058762025-01-1712.1 - 17.411.2Out
 Put
2025-01-17 PUT at $220.0-0.3480.00612432025-01-1714.0 - 18.912.9Out
 Put
2025-01-17 PUT at $225.0-0.38090.0065542025-01-1715.3 - 20.915.0Out
 Put
2025-01-17 PUT at $230.0-0.41530.00681482025-01-1717.0 - 23.016.71Out
 Put
2025-01-17 PUT at $235.0-0.4510.00682362025-01-1720.2 - 25.819.4In
 Put
2025-01-17 PUT at $240.0-0.48790.00713082025-01-1722.9 - 27.740.55In
 Put
2025-01-17 PUT at $245.0-0.52460.00711192025-01-1725.4 - 30.923.98In
 Put
2025-01-17 PUT at $250.0-0.57560.00762422025-01-1725.5 - 34.035.0In
 Put
2025-01-17 PUT at $255.0-0.61450.0075322025-01-1728.6 - 37.033.5In
 Put
2025-01-17 PUT at $260.0-0.66350.00722832025-01-1732.2 - 40.641.1In
 Put
2025-01-17 PUT at $265.0-0.69840.0071722025-01-1735.7 - 43.969.74In
 Put
2025-01-17 PUT at $270.0-0.74770.0065462025-01-1739.2 - 47.548.1In
 Put
2025-01-17 PUT at $275.0-0.77920.006612025-01-1743.8 - 51.566.45In
 Put
2025-01-17 PUT at $280.0-0.80890.005502025-01-1747.9 - 55.747.4In
 Put
2025-01-17 PUT at $285.0-0.87090.004402025-01-1751.6 - 59.844.87In
 Put
2025-01-17 PUT at $290.0-0.92630.002702025-01-1756.1 - 64.567.06In
 Put
2025-01-17 PUT at $295.0-0.78120.004602025-01-1760.8 - 68.747.7In
 Put
2025-01-17 PUT at $300.0-0.7580.004402025-01-1765.1 - 74.8100.0In
 Put
2025-01-17 PUT at $305.0-0.76580.004202025-01-1770.3 - 79.690.0In
 Put
2025-01-17 PUT at $310.0-0.76910.00422025-01-1775.0 - 84.7102.5In
 Put
2025-01-17 PUT at $315.0-0.79370.003702025-01-1780.0 - 89.158.94In
 Put
2025-01-17 PUT at $320.0-0.78960.003602025-01-1785.0 - 94.358.71In
 Put
2025-01-17 PUT at $325.0-0.7930.003502025-01-1790.0 - 99.370.9In
 Put
2025-01-17 PUT at $330.0-0.79340.003402025-01-1795.0 - 104.565.77In
 Put
2025-01-17 PUT at $335.0-0.80240.003202025-01-17100.0 - 109.40.0In
 Put
2025-01-17 PUT at $340.0-0.80770.003102025-01-17105.0 - 114.20.0In
 Put
2025-01-17 PUT at $345.0-0.80730.00302025-01-17110.0 - 119.40.0In
 Put
2025-01-17 PUT at $350.0-0.81240.002902025-01-17115.0 - 124.296.56In
 Put
2025-01-17 PUT at $355.0-0.80910.002802025-01-17120.0 - 129.60.0In
 Put
2025-01-17 PUT at $360.0-0.81620.002702025-01-17125.0 - 134.2116.3In
 Put
2025-01-17 PUT at $365.0-0.81540.002702025-01-17130.0 - 139.40.0In
 Put
2025-01-17 PUT at $370.0-0.81460.002602025-01-17135.0 - 144.60.0In
 Put
2025-01-17 PUT at $375.0-0.820.002502025-01-17140.0 - 149.30.0In
 Put
2025-01-17 PUT at $380.0-0.81530.002502025-01-17145.0 - 154.80.0In
 Put
2025-01-17 PUT at $385.0-0.81670.002402025-01-17150.0 - 159.80.0In
 Put
2025-01-17 PUT at $390.0-0.82170.002402025-01-17155.0 - 164.50.0In
 Put
2025-01-17 PUT at $395.0-0.82860.002302025-01-17160.0 - 169.30.0In
 Put
2025-01-17 PUT at $400.0-0.8310.002302025-01-17165.0 - 174.2123.2In
 Put
2025-01-17 PUT at $410.0-0.82280.002202025-01-17175.0 - 184.8128.9In
 Put
2025-01-17 PUT at $420.0-0.83380.002102025-01-17185.0 - 194.30.0In
 Put
2025-01-17 PUT at $430.0-0.82540.002102025-01-17195.0 - 204.90.0In
 Put
2025-01-17 PUT at $440.0-0.83360.00202025-01-17205.0 - 214.60.0In
 Put
2025-01-17 PUT at $450.0-0.83380.001902025-01-17215.0 - 224.70.0In
 Put
2025-01-17 PUT at $460.0-0.83510.001902025-01-17225.0 - 234.70.0In
 Put
2025-01-17 PUT at $470.0-0.83740.001802025-01-17235.0 - 244.60.0In

Biogen Total Stockholder Equity Over Time

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
   Total Stockholder Equity   
       Timeline  

Biogen Common Stock Shares Outstanding Over Time

The total number of shares of a company's common stock that are currently owned by all its shareholders.
   Common Stock Shares Outstanding   
       Timeline  

Biogen Total Stockholder Equity

Total Stockholder Equity

15.54 Billion

At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Biogen Corporate Executives

Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael CPAExecutive CFOProfile

Already Invested in Biogen Inc?

The danger of trading Biogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.011
Earnings Share
8.01
Revenue Per Share
66.688
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0486
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.